Form 8-K - Current report:
SEC Accession No. 0001558370-24-000060
Filing Date
2024-01-04
Accepted
2024-01-04 16:16:01
Documents
49
Period of Report
2024-01-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apre-20240104x8k.htm   iXBRL 8-K 40215
2 EX-99.1 apre-20240104xex99d1.htm EX-99.1 16626
3 EX-99.2 apre-20240104xex99d2.htm EX-99.2 52227
4 GRAPHIC apre-20240104xex99d2g001.jpg GRAPHIC 106333
5 GRAPHIC apre-20240104xex99d2g002.jpg GRAPHIC 335203
6 GRAPHIC apre-20240104xex99d2g003.jpg GRAPHIC 171668
7 GRAPHIC apre-20240104xex99d2g004.jpg GRAPHIC 146100
8 GRAPHIC apre-20240104xex99d2g005.jpg GRAPHIC 176174
9 GRAPHIC apre-20240104xex99d2g006.jpg GRAPHIC 56541
10 GRAPHIC apre-20240104xex99d2g007.jpg GRAPHIC 148590
11 GRAPHIC apre-20240104xex99d2g008.jpg GRAPHIC 172400
12 GRAPHIC apre-20240104xex99d2g009.jpg GRAPHIC 108439
13 GRAPHIC apre-20240104xex99d2g010.jpg GRAPHIC 131487
14 GRAPHIC apre-20240104xex99d2g011.jpg GRAPHIC 128800
15 GRAPHIC apre-20240104xex99d2g012.jpg GRAPHIC 90859
16 GRAPHIC apre-20240104xex99d2g013.jpg GRAPHIC 57428
17 GRAPHIC apre-20240104xex99d2g014.jpg GRAPHIC 175777
18 GRAPHIC apre-20240104xex99d2g015.jpg GRAPHIC 135941
19 GRAPHIC apre-20240104xex99d2g016.jpg GRAPHIC 143061
20 GRAPHIC apre-20240104xex99d2g017.jpg GRAPHIC 59075
21 GRAPHIC apre-20240104xex99d2g018.jpg GRAPHIC 179037
22 GRAPHIC apre-20240104xex99d2g019.jpg GRAPHIC 176645
23 GRAPHIC apre-20240104xex99d2g020.jpg GRAPHIC 141129
24 GRAPHIC apre-20240104xex99d2g021.jpg GRAPHIC 163780
25 GRAPHIC apre-20240104xex99d2g022.jpg GRAPHIC 58659
26 GRAPHIC apre-20240104xex99d2g023.jpg GRAPHIC 167579
27 GRAPHIC apre-20240104xex99d2g024.jpg GRAPHIC 91072
28 GRAPHIC apre-20240104xex99d2g025.jpg GRAPHIC 61166
29 GRAPHIC apre-20240104xex99d2g026.jpg GRAPHIC 125043
30 GRAPHIC apre-20240104xex99d2g027.jpg GRAPHIC 154611
31 GRAPHIC apre-20240104xex99d2g028.jpg GRAPHIC 140367
32 GRAPHIC apre-20240104xex99d2g029.jpg GRAPHIC 117201
33 GRAPHIC apre-20240104xex99d2g030.jpg GRAPHIC 135489
34 GRAPHIC apre-20240104xex99d2g031.jpg GRAPHIC 78948
35 GRAPHIC apre-20240104xex99d2g032.jpg GRAPHIC 161431
36 GRAPHIC apre-20240104xex99d2g033.jpg GRAPHIC 112683
37 GRAPHIC apre-20240104xex99d2g034.jpg GRAPHIC 148704
  Complete submission text file 0001558370-24-000060.txt   6539881

Data Files

Seq Description Document Type Size
38 EX-101.SCH apre-20240104.xsd EX-101.SCH 3993
39 EX-101.DEF apre-20240104_def.xml EX-101.DEF 2842
40 EX-101.LAB apre-20240104_lab.xml EX-101.LAB 17243
41 EX-101.PRE apre-20240104_pre.xml EX-101.PRE 11353
43 EXTRACTED XBRL INSTANCE DOCUMENT apre-20240104x8k_htm.xml XML 4811
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 24512109
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)